This symposium, presented at ICIEM 2025, provides an overview of sepiapterin as a treatment for phenylketonuria (PKU) and the current PKU disease landscape
All congress activities
International congresses, conferences and meetings offer the opportunity to share data and drive discussion that can progress the management of conditions such as phenylketonuria (PKU). Access our content from recent congresses and society meetings here.
|
Congress
Topic
Type
Year
This poster, presented at ACMG 2025, describes interim results from the ongoing APHENITY extension study, which evaluated the effect of sepiapterin on dietary Phe tolerance in a broad population of phenylketonuria (PKU) participants
This symposium, presented at SSEIM 2024, provides an overview of sepiapterin as a potential treatment for phenylketonuria (PKU) and its implications for patient management
Always consult the prescribing information before prescribing any products
MED-US-CORP-2500008 | November 2025
MED-US-PKU-2600003 | February 2026